It has been reported that the activity of GGT is increased in cancers resistant to chemotherapy, and the removal of glutathione, the substrate of GGT, in tumors inhibits tumor progression and metastasis (Mena et al., 2007; Hanigan, 2014). Here, GGT1 is linked to cancer.